FAIL (the browser should render some flash content, not this).
               Latest Research

 

Novak M., Vetvicka V.,: Glucan as Biological Response Modifiers. Endocrine, Metabolic & Immune Disorders 9, 67-75, 2009 PDF DOCUMENT

Vetvicka V., Vetvickova J.,: Effects of Glucan on Immunosuppressive Actions of Mercury. Journal of Medicinal Food 12, 2009 (Link)

Vetvicka V., Vetvickova J.,: Effects of yeast-derived B-glucans on blood cholesterol and macrophage functionality. Journal of Immunotoxicology  6, 2009 (Link)

Vetvicka V., Vetvickova J., Jamois Frank, J-C Yvin: Enhancing effects of new biological response modifier B-1,3 Glucan sulfate PS3 on immune reactions. Biomedicine Pharm 62, 2008 PDF DOCUMENT

Vetvicka V., Vetvickova J.: A Comparison of Injected and Orally Administered B-glucans. Jana, 11, 2008 PDF DOCUMENT

Novak M., Vetvicka V.: Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. Journal of Immunotoxicology, 5, 2008  PDF DOCUMENT

Vetvicka V., Vetvickova J.: An Evaluation of the Immunological Activities of Commercially Available B1, 3-Glucans. JANA, Vol. 10, No 1, 2007 PDF DOCUMENT

Read  more



 

 

 

 

Version Française

 

 

Free Web Hit Counter By CSS HTML Tutorial

Last Update: December 9, 2009


If you are having problems with this new flash version
 

CLICK HERE

to let me know
 
FAIL (the browser should render some flash content, not this).




This non-commercial, non-profit site is intended to provide information to anybody looking for help and information when facing health challenges, particularly cancer. The information is based on our areas of research and expertise, i.e. cancer, beta glucans and Cathepsin D. It is our intention to keep this site alive and up-dated with additional information whenever possible.

read more about me

 

 




            My new book:

Beta Glucan: Nature's Secret

Click here for 6 sample pages (pdf)


Book contains 119 pages, including 24 color figures.

You can buy it from Amazon.com






_______________________________________________________________________



The University of Louisville is seeking a company interested in commercializing a novel method for the early diagnosis of a wide range of cancers

 

Applications

 

      Early cancer diagnosis and prognosis achieved via processing serum samples

Screening for many, if not all types of cancer


read more (pdf)

    __________________________________________________________________________________________________________________________________________

     

    _______________________________________________________________________________________________________________________________________